Elvira D'Ippolito

11PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 10, 2026
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination.

Linda Warmuth, Sarah Dötsch, Manuel Trebo

|Oct 03, 2025
Vaccination-induced T cell responses maintain polyclonality with high antigen receptor avidity.

Katharina Kocher, Felix Drost, Abel Mekonnen Tesfaye

|Sep 19, 2025
Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunities.

Karl Petri, Elvira D'Ippolito, Annette Künkele

|Apr 26, 2024
Advances in preclinical TCR characterization: leveraging cell avidity to identify functional TCRs.

Andreas Carr, Laura M Mateyka, Sebastian J C Scheu

|Feb 28, 2023
Long-term persistence and functionality of adoptively transferred antigen-specific T cells with genetically ablated PD-1 expression.

Sarah Dötsch, Mortimer Svec, Kilian Schober

|Oct 27, 2022
Gene Signatures of T-Cell Activation Can Serve as Predictors of Functionality for SARS-CoV-2-Specific T-Cell Receptors.

Laura M Mateyka, Philipp M Strobl, Sebastian Jarosch

Pageof 2

Frequent Collaborators

9 joint publications

Dirk H Busch

4 joint publications

Kilian Schober

4 joint publications

Sebastian Jarosch

3 joint publications

Karolin I Wagner